Lasa Supergenerics Ltd (LASA)

37.30 -0.35 (-0.93%)
Close INR Disclaimer

Lasa Supergenerics Ltd Company Profile

Equity Type
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products, such as anthelmintics. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.
Contact Information
Andheri Kurla Road Andheri East Mumbai,400059 India
Top Executives
Omkar Pravin Herlekar 41 2016 Chairman & MD
Ekta Avtar Gurnasinghani 0 2017 Non-Executive & Independent Director
Ajay Hareshlal Sukhwani 0 2017 Non-Executive Independent Director
Manali Roop Bhagtani 0 2018 Non-Executive & Independent Director
Hardesh Raja Tolani 0 2017 Non-Executive & Independent Director
Shivanand Gajanan Hegde 61 2017 Whole Time Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles